OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - ROCHE GS Share Price

Certificat

DE000SQ9LEB7

Market Closed - Börse Stuttgart 01:18:16 06/05/2024 pm IST
2.57 EUR +16.29% Intraday chart for OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - ROCHE GS
Current month-7.22%
1 month-19.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
06/24/06 2.57 +16.29% 0
03/24/03 2.21 -22.73% 0
02/24/02 2.86 +3.25% 0
30/24/30 2.77 -7.36% 0
29/24/29 2.99 +6.79% 0

Delayed Quote Börse Stuttgart

Last update May 06, 2024 at 01:18 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SQ9LEB
ISINDE000SQ9LEB7
Date issued 31/01/2023
Strike 192.7 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 9.58
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.82
Lowest since issue 2.21

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
218.5 CHF
Average target price
279.4 CHF
Spread / Average Target
+27.87%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW